Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?

被引:20
作者
Fanta, Michael [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Obstet & Gynecol, Prague 12851 2, Czech Republic
[2] Gen Univ Hosp Prague, Prague 12851 2, Czech Republic
关键词
Androgens; breast; endometrium; estrogens; estrogen-dependant tumours; polycystic ovary syndrome; CANCER-RISK; ORAL-CONTRACEPTIVES; ENDOMETRIAL CANCER; WOMEN; PREVALENCE; PCOS;
D O I
10.3109/09513590.2012.730575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting women of fertile age. It is associated with several risk factors and long-term health consequences. Chronic anovulation combined with relative estrogen excess and consequent prolonged stimulatory effect on the endometrium can lead to the pathogenesis of hormonal dependant carcinoma. PCOS is thus traditionally reported to be associated with increased risk of endometrial, as well as breast and ovarian cancers. This article provides a critical literature review of the relationship between PCOS and the incidence of estrogen-dependant gynecological tumours, and it then discusses whether the commonly cited risk factor association can be substantiated by high quality studies which comply with the requirements of "evidence-based medicine."
引用
收藏
页码:145 / 147
页数:3
相关论文
共 24 条
[1]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[2]   Androgen excess in women: Experience with over 1000 consecutive patients [J].
Azziz, R ;
Sanchez, LA ;
Knochenhauer, ES ;
Moran, C ;
Lazenby, J ;
Stephens, KC ;
Taylor, K ;
Boots, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :453-462
[3]   Metabolic disorders and breast cancer risk (United States) [J].
Baron, JA ;
Weiderpass, E ;
Newcomb, PA ;
Stampfer, M ;
Titus-Ernstoff, L ;
Egan, KM ;
Greenberg, ER .
CANCER CAUSES & CONTROL, 2001, 12 (10) :875-880
[4]  
Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1
[5]  
BERCHUCK A, 1990, OBSTET GYNECOL, V75, P255
[6]   Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review [J].
Chittenden, B. G. ;
Fullerton, G. ;
Maheshwari, A. ;
Bhattacharya, S. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (03) :398-405
[7]   The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients [J].
Cibula, D ;
Fanta, M ;
Vrbikova, J ;
Stanicka, S ;
Dvorakova, K ;
Hill, M ;
Skrha, J ;
Zivny, J ;
Skrenkova, J .
HUMAN REPRODUCTION, 2005, 20 (01) :180-184
[8]   A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[9]  
ESCOBEDO LG, 1991, OBSTET GYNECOL, V77, P124
[10]   Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women [J].
Fanta, Michael ;
Cibula, David ;
Vrbikova, Jana .
GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (03) :154-157